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DNA damage-induced metaphase I arrest is
mediated by the spindle assembly checkpoint and
maternal age
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In mammalian oocytes DNA damage can cause chromosomal abnormalities that potentially
lead to infertility and developmental disorders. However, there is little known about the
response of oocytes to DNA damage. Here we ﬁnd that oocytes with DNA damage arrest at
metaphase of the ﬁrst meiosis (MI). The MI arrest is induced by the spindle assembly
checkpoint (SAC) because inhibiting the SAC overrides the DNA damage-induced MI arrest.
Furthermore, this MI checkpoint is compromised in oocytes from aged mice. These data lead
us to propose that the SAC is a major gatekeeper preventing the progression of oocytes
harbouring DNA damage. The SAC therefore acts to integrate protection against both
aneuploidy and DNA damage by preventing production of abnormal mature oocytes and
subsequent embryos. Finally, we suggest escaping this DNA damage checkpoint in maternal
ageing may be one of the causes of increased chromosome anomalies in oocytes and
embryos from older mothers.
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D
NA damage is a constant threat to cells and its harmful
effects accumulate with age1,2. Cells with long lifespans
are therefore particularly prone to accumulating DNA
damage. One such population is the mammalian oocyte, which
remains arrested at G2/prophase in the ovary for the entire
reproductive lifespan that can be 40 years in humans.
The resting pool of primordial follicles is particularly sensitive
and DNA damage leads to apoptosis via the Tap63 pathway3–6.
There is much less known about DNA damage in oocytes at later
stages of development when the Tap63 pathway is inactive. We
recently showed that fully grown oocytes are not capable of
establishing a robust G2/prophase checkpoint in response to
DNA damage. The induction of double-strand breaks (DSBs) by
genotoxic agents such as Etoposide and Doxorubicin does not
arrest mouse oocytes in G2/prophase but, instead, allows entry
into the ﬁrst meiotic M-phase (MI)7. Etoposide and Doxorubicin
are topoisomerase II poisons that form stable complexes with the
DNA and topoisomerase II, a DNA unwinding enzyme and
therefore prevent re-ligation of DNA strands, leading to DNA
DSBs8. Besides DSBs, other DNA lesions, such as interstrand
crosslinks, also fail to induce the launch of a G2/prophase
checkpoint in mouse oocytes9. Therefore, a checkpoint during the
meiotic M-phase may raise the only signiﬁcant obstacle to DNA
damage entering embryonic development.
Interestingly, in oocytes, maternal age-related genomic
instability has been linked to meiotic M-phase chromosome
segregation errors such that over 60% of oocytes in women over
the age of 40 have major chromosomal problems10,11. To date,
the cause of increased aneuploidy and chromosomal anomalies in
oocytes from aged mice has been attributed mainly to the loss of
Cohesin, the protein complex responsible for holding
chromosomes together12–15 but also to the failure to correct
erroneous microtubule–kinetochore interactions16 and to a leaky
SAC11,17,18.
In oocytes undergoing meiotic M-phase, the DNA damage
response and how it is impacted by maternal age is poorly
understood. Here, we report that exposing oocytes to genotoxic
agents causes SAC-dependent M-phase arrest at MI.
Nevertheless, we ﬁnd that, in oocytes from mice of advanced
maternal age, DNA damage-induced MI arrest is compromised
and this appears to be due to disruption of the SAC. These results
highlight the importance of the SAC for preventing DNA
damage-induced genomic instability in oocytes and identify
DNA damage as a potential cause for age-related infertility.
Results and Discussion
DNA damage in oocytes leads to MI arrest. In the absence of a
robust G2/M DNA damage checkpoint the potential to create
mature eggs capable of undergoing fertilization carries the risk of
creating embryos with chromosomal abnormalities. We therefore
set out to investigate the fate of oocytes carrying DNA damage
into the ﬁrst meiotic division. DNA damage was induced in fully
grown, prophase-arrested germinal vesicle (GV) stage oocytes
using well characterized genotoxic agents that cause DSBs,
namely Etoposide (100 mgml 1, 1 h), Phleomycin (10 mgml 1,
1 h) and Doxorubicin (20 mM, 1 h)7,9,19. The oocytes were then
monitored for progression through meiosis I. Consistent with
previous studies7,9, oocytes with DNA damage do not show a
G2/prophase checkpoint, irrespective of the agent used
(Fig. 1a,b). However, our data show that o20% of oocytes
treated with Etoposide, Phleomycin or Doxorubicin progress
through meiosis I and extrude a ﬁrst polar body (Pb1), compared
with more than 80% of control oocytes (Fig. 1a,b). Since all agents
cause a similar MI arrest phenotype, Etoposide will be used to
induce DNA damage in all subsequent experiments. We have
conﬁrmed that the DNA damage induced in prophase-arrested
oocytes persists through to MI as demonstrated by gH2AX
labelling (Fig. 1c).
To investigate the target of DNA damage in causing MI arrest
we analysed the spindle and chromosome conﬁguration in
Etoposide-treated oocytes. Analysis of spindle size and shape
shows that DSBs do not have any signiﬁcant effect on the spindle
(Fig. 1d,e). However, Etoposide treatment does cause chromatin
aggregations and reduced chromosome alignment at the
metaphase plate (Fig. 1c,d and Supplementary Fig. 1). We also
ﬁnd evidence of kinetochore-free chromosome fragments in
nearly 30% of Etoposide-treated oocytes (Fig. 1f,g). If these
oocytes progressed through MI, the fragments would not
participate in chromosome segregation, thereby, causing the
generation of oocytes with chromosomal abnormalities and
altered DNA content. These results show that oocytes respond
to DSBs by establishing an MI arrest. This DNA damage MI
checkpoint therefore provides a mechanism of avoiding the
production of embryos that show chromosomal abnormalities
and potential genomic instability.
The SAC is active in DNA-damaged MI-arrested oocytes.
To examine whether MI arrest occurred before activation of the
anaphase promoting complex/cyclosome (APC/C), we expressed
Geminin-GFP (green ﬂuorescent protein) in oocytes and
monitored its destruction in control and Etoposide-treated
oocytes. Geminin has the advantage in this assay that, unlike
other APC substrates, it does not have a role in meiotic pro-
gression and therefore is less likely to interfere with meiosis20.
Etoposide-treated oocytes progressing into MI show stable levels
of Geminin-GFP for a number of hours and fail to extrude Pb1
(Fig. 2a,b). In contrast, control oocytes show rapid degradation of
Geminin-GFP by 8 h post germinal vesicle breakdown (GVBD;
Fig. 2a,b) and undergo Pb1 extrusion. Cyclin B1 degradation has
also been shown to be inhibited in oocytes with Bleomycin-
induced DNA damage19. These results show that DSBs cause
prometaphase/metaphase arrest at MI.
Failure to activate the APC/C implicates a role for the SAC in
the DNA damage-induced MI arrest. The SAC operates
physiologically to sequester Cdc20 and inhibit the APC/C so
that anaphase onset is delayed until all chromosomes are under
tension on the M-phase spindle. SAC activity is regulated
by a protein complex that includes Mad2, Bub1, BubR1 and
Mps1, which accumulate on unattached kinetochores21–26. SAC
function is regulated at two levels: the level of kinetochore–
microtubule attachment, which is monitored by factors such as
Mad2 and the level of kinetochore tension, which is controlled by
factors such as Bub1 and BubR1 (refs 24–26). To examine if the
SAC is responsible for DNA damage-induced MI arrest, we used
immunoﬂuorescence to determine whether Mad2 and Bub1
remain on the kinetochores. In control conditions, Mad2 is
removed from kinetochores by 8 h post GVBD22 and we ﬁnd that
only 3% of the kinetochore population shows any detectable
Mad2 staining (Fig. 2c,d). However, after DNA damage, an
average of 38% of kinetochores in each Etoposide-treated oocyte
are Mad2 positive (Fig. 2c,d). Similar results are found in
Phleomycin-treated oocytes where 34% of kinetochores are
decorated with Mad2 (Supplementary Fig. 2). Unlike
Nocodazole-treated cells where practically all the kinetochores
are Mad2 positive, in Etoposide-treated cells more than 60% of
kinetochores have obtained kinetochore–microtubule attachment
(Fig. 2c,d). Similarly, in Etoposide-treated oocytes, Bub1 is
strongly localized at kinetochores at the time when control
oocytes enter anaphase showing no detectable Bub1 kinetochore
accumulation (Fig. 2e). Although it has been reported in some
mitotic cells that SAC proteins can be found at sites of DNA
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damage27,28, we ﬁnd that SAC proteins are exclusively localized
to kinetochores (Fig. 2c–e). This is veriﬁed by image analysis
showing that the level of colocalization of Mad2 or Bub1
with CREST (calcinosis, Raynaud’s phenomenon, esophageal
dysmotility, sclerodactyly, telangiectasia) is the same regardless
of whether or not DSBs have been induced (Fig. 2f). This ﬁnding
implies that, in oocytes, M-phase arrest in response to
DNA damage is a result of the kinetochores sensing peri-
centromeric damage or of inappropriate kinetochore–microtubule
interactions/tension due to DNA damage and not of SAC
activation at the site of the DSB. Thus, oocytes with DNA damage
fail to activate the APC/C and show an accumulation of SAC
proteins at kinetochores, strongly implicating the SAC in the
DNA damage-induced MI arrest.
The SAC establishes DNA damage-induced MI arrest. To
identify the importance of the SAC in regulating the MI response
to DNA damage we have suppressed the SAC using three
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Figure 1 | DNA damage induces MI arrest in mouse oocytes. (a) Oocytes were treated with Etoposide (100mgml 1), (b) Phleomycin (10 mgml 1) or
Doxorubicin (20 mM) for 1 h during the GV stage and released from IBMX. First polar body (Pb1) extrusion was scored 18 h after release from IBMX
and oocytes continued to be monitored for Pb1 extrusion until at least 24 h from IBMX release. The total number of oocytes examined is shown in
parentheses. nZ3 experiments. (c) DNA damage induced at GV stage persists to MI. Representative images of gH2AX and DNA labelling in control and
Etoposide-treated oocytes ﬁxed 1 h post GVBD. TotalZ20 oocytes/group from three independent experiments. (d,e) Spindle formation is grossly normal in
control and Etoposide-treated oocytes. (d) Representative images of microtubule and DNA organization in MI oocytes exposed to DNA damage ﬁxed 8 h
post GVBD. (e) The spindle length and width of oocytes represented in d are the same under control and Etoposide conditions; n¼ 3 experiments.
(f,g) Kinetochore-free DNA fragments are generated by Etoposide treatment. (f) Representative images from immunostained Etoposide-treated MI
oocytes ﬁxed 8 h post GVBD. CREST is used to label kinetochores. Arrowheads: Etoposide-induced kinetochore-free DNA fragments. White box: DNA
fragment shown in higher magniﬁcation in f’. Hoechst 33342 was used for DNA staining, as in c and d. (g) Oocytes from ﬁve experiments performed under
the conditions of f were examined for the presence of kinetochore-free DNA fragments. Approximately 30% of Etoposide-treated oocytes possess at least
one kinetochore-free DNA fragment as in f. Solid bars, 10mm. Dashed bar, 2mm. Data are represented as mean. Error bars show s.e.m.’s; *Po0.0001;
unpaired t-test.
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independent approaches and examined the effects on MI pro-
gression under conditions of DNA damage. We ﬁnd that deple-
tion of Mad2 by the use of a Mad2 morpholino (MO), inhibition
of Bub1 by a dominant-negative form of the protein (Bub1dn) or
of Mps1 by the use of the speciﬁc inhibitor AZ3146 (Mps1i),
allows oocytes with DNA damage to complete MI and extrude a
Pb1 at rates of 83%, 64% and 85%, respectively (Fig. 3a,b). We
veriﬁed that Mad2 MO and Mps1i cause SAC inactivation by
determining that Mad2 accumulation in kinetochores is largely
diminished in the treated oocytes (Supplementary Fig. 3a,b).
Similarly, Bub1 dn injection leads to a more than 60% reduction
in BubR1 levels (Supplementary Fig. 3c,d). The rate of Pb1 for-
mation when the SAC is perturbed is similar to control oocytes
not exposed to any DNA damage (79–84%) and much higher
than in oocytes with DNA damage and an intact SAC (B10%)
(Fig. 3a,b). Although, these studies show that inhibition of the
SAC allowed oocytes with DNA damage to progress through MI,
we could not rule out an effect of DNA damage on the timing of
meiotic progression. To address this we monitored Pb1 formation
in Mad2-depleted oocytes and found that DNA damage led to
delayed completion of MI relative to controls (B12 h compared
withB9 h post GVBD, respectively; Fig. 3c). Mad2-depletion was
clearly effective in these experiments because, as expected, Mad2
MO-injected control oocytes progressed through MI faster than
controls with an intact SAC (Fig. 3c). Oocytes with DNA damage
that progressed through to meiosis II (MII) in the presence of
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Figure 2 | The SAC is active during MI arrest in response to DNA damage. (a,b) The APC/C is not activated in DNA-damaged oocytes.
(a) Representative ﬂuorescent traces of oocytes micro-injected with Geminin-GFP at the GV stage, incubated in the presence or absence (Control) of
Etoposide for 1 h during the GV stage and then released from IBMX. Normalization was performed by using the formula F 100/Fmax. Pb1, ﬁrst polar body.
(b) The rate of destruction of Geminin-GFP in oocytes from a was signiﬁcantly higher in controls at the time of the metaphase to anaphase transition in MI.
At the same time, Etoposide-treated oocytes remain arrested at prometaphase since they hardly show any level of Geminin-GFP destruction.
(c,d) Etoposide-treated oocytes arrested in MI are Mad2 positive. (c) Representative z-projection images of immunostaining for CREST and Mad2 in
non-treated controls and oocytes treated with Etoposide or Nocodazole (100 nM). Oocytes were ﬁxed 8 h post GVBD. The colocalization of CREST with
Mad2 shows that the SAC is only active at the kinetochore region. (d) Proportion of Mad2 positive kinetochores 8 h post GVBD. Data analysed from
experiments shown in c. The total number of cells measured is shown in parentheses; nZ3 experiments. (e) Etoposide-treated oocytes arrested in MI are
Bub1 positive. Representative z-projection images of immunostaining for CREST and Bub1 in non-treated controls and oocytes treated with Etoposide.
Oocytes were ﬁxed 8 h post GVBD. The control oocyte shown is undergoing anaphase at which point Bub1 staining is lost from the kinetochores. At the
same time, Etoposide-treated oocytes remain arrested at MI with high Bub1 staining. In all, Z20 oocytes were examined per group; n¼ 3 experiments.
(f) SAC components are only present at the kinetochore region of DNA-damaged MI oocytes. Prometaphase control and Etoposide-treated oocytes were
ﬁxed at 4 and 8 h post GVBD for identifying the level of co-staining of CREST with Mad2 or Bub1. The 4 h time point was chosen for Mad2-CREST
colocalization because Mad2 shows very low staining at 8 h in controls. CREST and SAC components are colocalized at the same levels in control and
Etoposide conditions. Scale bars, 10mm. Data are represented as mean. Error bars show s.e.m.’s; *Po0.0001; unpaired t-test.
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Mps1i showed spindle disruption and chromosome scattering
with evidence of chromatin present in the cytoplasm completely
detached from the spindle. This was not seen in untreated control
oocytes and Mps1i-treated control oocytes only showed mild
chromosomal misalignment in 45% of oocytes (Fig. 3d–f).
These three different approaches provide consistent data that
demonstrate that SAC activity is necessary for DNA damage-
induced MI arrest and that DNA damage may induce enhanced
SAC activity, or SAC-dependent pathways that lead to a delay in
progression through MI.
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The Mos/MAPK pathway in oocytes is activated just after
GVBD and has a number of roles in meiosis including a well-
established role in maintenance of MII arrest29,30. Recent data
have shown a role for MAPK in regulating the meiotic SAC31,
suggesting it may also be important in ensuring oocytes with
DNA damage do not progress. We targeted the Mos/MAPK
pathway by depleting Mos through a well characterized Mos-
speciﬁc MO31 and by inhibiting the MAPK activating kinase,
MEK, with the pharmacological inhibitor UO126 (MAPKi) in
Etoposide-treated oocytes. We ﬁnd that Mos depletion or MAPK
inhibition ablate the DNA damage-induced MI checkpoint
leading to 53% and 76% Pb1 extrusion, respectively (Fig. 3g).
Therefore, the Mos/MAPK pathway participates in the
establishment of MI arrest in the presence of damaged DNA.
The role of the Mos/MAPK pathway, most possibly, involves the
enhancement of SAC activity since MAPK is important for
the kinetochore localization of SAC proteins31–33. Besides the
importance for meiotic processes, the identiﬁcation of the
Mos/MAPK pathway as a regulator of mammalian M-phase
checkpoint function may shed light on its action in mitosis and
speciﬁcally, in Mos-positive tumours34,35.
We then examined if a traditional DNA damage response
(DDR) intersects with the SAC to promote and maintain an MI
arrest. The G2 DDR pathway depends on ataxia telangiectasia
mutated (ATM) kinase-dependent cell cycle arrest36,37. By using a
speciﬁc well-characterized pharmacological inhibitor against
ATM (ATMi, Calbiochem)7 we ﬁnd that ATM inhibition does
not prevent MI arrest of DNA-damaged oocytes (B10% Pb1
extrusion; Supplementary Fig. 4a). Furthermore, ATM inhibition
does not prevent SAC components, such as Mad2, from
accumulating on the kinetochores of DNA-damaged MI oocytes
(Supplementary Fig. 4b,c). Therefore, an ATM-dependent DDR
mechanism does not participate in SAC establishment or
maintenance in DNA-damaged oocytes.
MI arrest is compromised in DNA damaged aged oocytes.
To investigate whether a compromised DNA damage checkpoint
is a feature of aged oocytes we have induced DNA damage in
oocytes from mice 450 weeks of age and examined their ability
to progress through MI. We verify previous reports13,38 that
young and aged oocytes progress through and complete MI
at similar rates (B80%) (Fig. 4a). However, after DNA
damage, over 50% of oocytes from old mothers progress
through MI compared with only 12% of controls (Fig. 4a).
We conﬁrmed that Etoposide treatment induces similar levels
of DNA damage in prophase-arrested young and old oocytes,
thus it appears unlikely that the ability of Etoposide-treated aged
oocytes to progress through MI is due to a reduced level of
damage (Supplementary Fig. 5). Although, a signiﬁcantly
increased proportion of aged oocytes do progress through MI
in the presence of DNA damage, the time course of this
progression is delayed by an average of 4 h compared with
control young oocytes (Fig. 4b). The DNA-damaged oocytes that
reach MII show gross abnormalities with deformed spindle
structures (Fig. 4c, Supplementary Fig. 6), scattered spindle
chromosomes and cytoplasmic chromatin (Fig. 4c–e), unlike
undamaged aged oocytes where, although there is chromosome
misalignment16,39,40, the chromosomes tend to be located at the
metaphase plate area (Fig. 4c–e). The combination of high rates
of MI exit with a delay in the timing of Pb1 extrusion and grossly
abnormal MII chromosome conﬁguration resembles that of
young Etoposide-treated oocytes under conditions of SAC
dysfunction (Fig. 3).
Given that we have shown the SAC is necessary for the DNA
damage MI checkpoint, a compromised SAC in aged oocytes may
explain the increased rate of MI progression. To test this, we have
measured SAC components in Etoposide-treated young and aged
oocytes 8 h post GVBD when the SAC in untreated control
oocytes is satisﬁed (Fig. 2c–e). We ﬁnd that Bub1 shows a 15%
decrease and BubR1 a 35% decrease in kinetochore accumulation
in Etoposide-treated aged oocytes compared with Etoposide-
treated young controls (Fig. 4f–h). We ﬁnd that Mad2 shows only
a small non-signiﬁcant decrease in aged oocytes (Fig. 4h). We also
examined kinetochore localization of Polo-like kinase 1 (Plk1) in
these conditions. Although, Plk1 is not considered a SAC
component its presence at kinetochores is an indication of an
active SAC41. Our data show that similar to BubR1, there is an
average 38% decrease in Plk1 at kinetochores of Etoposide-treated
aged oocytes. (Fig. 4h). This decrease in accumulation of SAC
components is also reﬂected by a similar 30% decrease in CREST
ﬂuorescence in Etoposide-treated old oocytes. Reduced CREST
staining in aged oocytes has also been observed by other
researchers18. These studies show that kinetochore localization
of key SAC components and regulators are disrupted in
Etoposide-treated aged oocytes, offering a likely explanation for
why aged oocytes can avoid the DNA damage MI checkpoint.
To determine if the compromised DNA damage checkpoint in
aged oocytes is due to a fundamental problem in kinetochore
function or if it is exclusive to DNA damage, we have quantiﬁed
SAC components in control conditions in young and aged
oocytes. The data show that a similar decrease in SAC
components and CREST labelling is seen in aged oocytes, even
in the absence of DNA damage (Supplementary Fig. 7).
Therefore, the inability of aged oocytes to launch a robust
checkpoint in response to DNA damage in MI is not likely to be
caused by inefﬁcient recruitment of SAC components, but due to
the low abundance of key SAC proteins and a general
compromise in kinetochore function in aged oocytes.
There is some controversy as to whether the SAC is
compromised in old oocytes. Initial studies indicated on the
basis that young and old oocytes have similar MI kinetics, that the
SAC is not compromised38. However, other studies have reported
that Mad2 levels are reduced on kinetochores of aged oocytes18,
while others have shown a decrease in mRNA for BubR1 and Plk1
in aged oocytes40,42. Our data provide further evidence that the
SAC is compromised in old oocytes and we offer this as a likely
explanation for the inability of aged oocytes to establish an
efﬁcient MI checkpoint in response to DNA damage.
Another possible explanation for the muted DDR in aged
oocytes is that they have depleted levels of Cohesin12,13,15. In
recent years it has been shown that Cohesin has an important role
in the DDR43,44 and has also been implicated in SAC regulation
in oocytes45. Therefore, we examined whether the absence of
Cohesin is sufﬁcient to silence the MI response to DNA damage.
We used a knockout (KO) mouse model where the meiosis-
speciﬁc Cohesin component Smc1b is removed46. As in the case
of aged mice, the Smc1b KO mice show signiﬁcant loss of
chromosome cohesion integrity47. We ﬁnd that Smc1b KO
oocytes show signiﬁcantly reduced rates of Pb1 extrusion
(49% versus 84% in WT oocytes) and that those that do
extrude a Pb1 take an average of 3 h longer to do so
(Supplementary Fig. 8a,b) possibly due to SAC activation.
Monitoring of Pb1 extrusion in Etoposide-treated Smc1b KO
and WT oocytes shows that they launch a similar DNA damage
MI checkpoint (Supplementary Fig. 8a), albeit somewhat less
effective than that seen in experiments described thus far (see
Fig. 1). Furthermore, the Etoposide-treated Smc1b KO and WT
oocytes that do progress through MI achieve this on average 6 h
later than untreated WT oocytes (Supplementary Fig. 8b). The
similar response of WT and Smc1b KO oocytes to DNA damage
suggests that loss of Cohesin is not responsible for the ability of
aged oocytes to bypass the DNA damage checkpoint in MI.
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Figure 4 | Aged oocytes carrying DSBs possess a weaker SAC than young oocytes. (a) DNA-damaged aged oocytes complete MI and extrude a Pb1.
Young and aged oocytes were monitored for Pb1 extrusion 18 h after release from IBMX. Etoposide was used at the GVstage; n¼ 11 experiments. (b) Young
and aged oocytes were monitored during oocyte maturation to determine the duration of MI. MI is prolonged under conditions of DNA damage in aged
oocytes compared with undamaged young oocytes; n¼ 3 experiments. (c–e) Etoposide-treated aged oocytes reaching the MII stage possess severely
abnormal chromatin conﬁguration and spindle structures. (c) Representative images of MII oocytes ﬁxed 18 h post GVBD and used for immunostaining
with b-tubulin and DNA staining with Hoechst 33342 to determine spindle structures and the state of the chromatin, respectively, following DNA damage
in aged oocytes at the GV stage. (d,e) Analysis of MII oocytes from c was performed as in Fig. 3e,f. Etoposide-treated aged MII oocytes are characterized
by scattered chromosomes within an expanded spindle structure and by cytoplasmic chromatin; n¼ 3 experiments. Arrow: misaligned chromosome;
arrowhead: cytoplasmic chromatin. The total number of oocytes examined in a–e is shown in parentheses. (f) Aged oocytes show lower BubR1
accumulation at the kinetochores following DNA damage. Representative z-projection images of immunostaining for CREST and BubR1 in young and aged
oocytes treated with Etoposide. Oocytes were ﬁxed 8 h post GVBD. (g) BubR1 accumulation in bivalents of young and aged oocytes. The arrow shows the
position of the kinetochore. Note the absence of BubR1 and the low CREST ﬂuorescence on the kinetochore region of the aged oocyte bivalent; n¼ 2
experiments. (h) Aged oocytes show lower accumulation of kinetochore components following DNA damage. Quantiﬁcation of Mad2, Bub1, BubR1, Plk1
and CREST kinetochore ﬂuorescence from experiments (n¼ 2) performed under the conditions shown in f. The number of kinetochores measured is shown
in parentheses. Data are represented as mean. Error bars show s.e.m.’s; *Po0.0001; **Po0.001; unpaired t-tests. Scale bars, 10mm. Dashed bar, 2 mm.
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In summary, genomic instability has been known to result
from DNA damage48,49. More speciﬁcally in oocytes, induction of
DNA damage in the form of DSBs at the G2/prophase
stage can cause abnormalities in chromosome structure50,51.
The implications become greater with age since aged oocytes
are more prone to genomic instability10,52. In the absence
of a traditional G2/prophase DNA damage checkpoint, the
mammalian oocyte has developed a meiotic M-phase checkpoint
to identify DNA damage and prevent the production of mature
oocytes that could lead to abnormal embryos. This MI DNA
Damage checkpoint is invoked by the SAC and can be modulated
by SAC regulators such as MAPK. Therefore, the SAC is the
major gatekeeper for oocytes harbouring DNA damage. We ﬁnd
that this gatekeeping function is compromised in oocytes from
old mice such that a larger proportion of aged oocytes progress
through MI in the presence of DNA damage. The explanation
appears to be that the SAC and/or kinetochore function
is disrupted in old oocytes, rather than due to loss of Cohesin.
The implication is that aged oocytes are not only
prone to aneuploidy10,11,53 but also to DNA damage-induced
chromosomal instability. This is particularly important in assisted
reproduction technologies due to the potential DNA damage that
may be caused to oocytes in the laboratory54,55. Our ﬁndings may
lead to new insights into the potential causes for the appearance
of chromosomal aberrations in the oocytes of women of advanced
reproductive age and further explain age-related infertility.
Methods
Mouse oocyte collection, culture and micro-injection. Young and aged oocytes
were collected from ovaries of 6–8-week old and 450-week old MF1 female mice,
respectively, 46–48 h following intraperitoneal administration of 7 international
units (IU) of Pregnant mare’s serum gonadotropin (PMSG; Intervet). Animal
experiments were covered by a Licence from the Home Ofﬁce (UK). For the
generation of Smc1b knockout mice a vector for targeting exon 10 of the mouse
Smc1b gene was designed. The vector was incorporated into W4/129S6 embryonic
stem cells (Taconic Inc.), which were then injected into C57BL/6 blastocysts46.
Cumulus-enclosed GV-stage oocytes were recovered by mechanical perforation of
the ovaries with a 27-guage needle. The cumulus cells were removed by repeated
pipetting using narrow-bore glass Pasteur pipettes. Oocytes were placed in drops of
M2 medium (Sigma) supplemented with 200 mM 3-isobutyl-1-methylxanthine
(IBMX; Sigma) under mineral oil (Sigma) on a 37 C hot block in order to keep the
oocytes arrested at the GV stage. Following collection and/or micro-injection, the
oocytes were released from IBMX and allowed to undergo oocyte maturation
(GVBD and progression through MI) in M16 at 37 C in a humidiﬁed atmosphere
of 5% CO2 in air. Micro-injection was performed in M2-IBMX56. Micropipettes
were inserted into oocytes using the negative capacitance overcompensation
capabilities of an electrophysiological ampliﬁer (World Precision Instruments).
Oocytes were immobilized with a holding pipette (Hunter Scientiﬁc). Injection
volume was estimated at 2–5% of total oocyte volume by cytoplasmic displacement.
Precise injection volume was achieved by the use of a pressure regulator
(Pneumatic PicoPump; World Precision Instruments). Micro-injection was used
for the introduction of cRNAs and Morpholinos (MOs) into oocytes.
cRNAs and MO oligonucleotides. For inhibiting the function of Bub1 we used
dominant negative Bub1 cRNA prepared from the pEFT7MCS-DnBub1 plasmid
(kind gift from Tim Hunt, Cancer Research UK)57. For expressing Geminin-GFP
we used a pcDNA3.1-Geminin-GFP (kind gift from Zoi Lygerou, University of
Patras, Greece)20. The cRNAs were prepared from the T7 promoter of the vectors.
cRNAs were synthesized and polyadenilated using the mMessage mMachine kit
(Ambion), puriﬁed in nuclease-free water through Rneasy columns (Quigen) to a
concentration of B1 mg ml 1, aliquoted and stored at  80 C.
For the inhibition of endogenous protein expression we used MOs (Gene Tools
LLC) that are fully characterized in mouse oocytes: Mos MO, 50-CACAGGCTTA
GAGGCGAAGGCATT-30 (ref. 31); Mad2 MO, 50-GCTCTCGGGCGAGCTGCTG
TGCCAT-30 (ref. 58). MOs were dissolved in nuclease-free water at a concentration
of 2mM. MO micro-injections were performed 5 h before release from IBMX.
Treatments. DSBs were performed by treating oocytes with 100mgml 1
Etoposide (Sigma), 10 mgml 1 Phleomycin (Sigma) or 20mM Doxorubicin
(Sigma) for 1 h at the GV stage. For inhibitor treatments, oocytes were incubated in
M16 containing 50 mM of the MAPK kinase inhibitor UO126 (Promega), 2 mM of
the Mps1 inhibitor AZ3146 (Santa Cruz Biotechnology, Inc.) and 40 mM of the
ATM inhibitor ATMi (Calbiochem). Inhibitors were applied 5 h post GVBD for the
duration of the experiment. Nocodazole (Calbiochem) was used at 100 nM
following GVBD and for the duration of the experiment.
Immunoﬂuorescence. For detection of gH2AX and b-tubulin oocytes were ﬁxed
in PBS containing 4% paraformaldehyde and then permeabilized in 0.5% Triton
X-100. The oocytes were then incubated in blocking buffer (PBS, 3% BSA) followed
by incubation with the primary antibodies59. For kinetochore immunolabelling,
oocytes were ﬁxed and permeabilized in PHEM buffer (60mM Pipes, 25mM
Hepes, 10mM EGTA and 2mM MgCl2) containing 4% paraformaldehyde
and 0.5% Triton X-100. For labelling we used the primary antibodies: rabbit
anti-gH2AX (1/800; 4418-APC; Trevigen), rabbit anti-Mad2 (1/300; PRB-452C;
Covance), mouse anti-b-tubulin (1/1000; T4026; Sigma), mouse Anti-Plk1 (1/300;
sc-17783, Santa Cruz Biotechnology), human CREST antiserum (1/300; a kind gift
from Bill Earnshaw, University of Edinburgh, UK and Greg FitzHarris, University
of Montreal, Canada), sheep anti-Bub1 and anti-BubR1 (1/300; kind gift from
Stephen Taylor, University of Manchester, UK). The secondary antibodies used
were: Alexa Fluor 488-conjugated goat anti-rabbit (1/500; A11008; Invitrogen),
Alexa Fluor 488-conjugated goat anti-mouse (1/500; A11029; Invitrogen), Alexa
Fluor 488-conjugated donkey anti-sheep (1/500; A11015; Invitrogen) and Alexa
Fluor 546-conjugated goat anti-human (1/500; A21089; Invitrogen). For DNA
staining, we incubated oocytes with Hoechst 33342 (10 mgml 1; Sigma). Serial z
sections of ﬁxed oocytes were acquired by the use of a laser-scanning confocal
microscope imaging system (LSM 510 META; Carl Zeiss) with the following band
pass emission ﬁlters: 385–470 nm (Hoechst 33342), 505–530 nm (Alexa Fluor 488)
and 585–615 nm (Alexa Fluor 546). z sections were analysed and projected into one
image using the LSM image browser (Carl Zeiss).
Epiﬂuorescence imaging. An inverted microscope (Axiovert 100; Carl Zeiss)
equipped with an interline cooled CCD camera (Princeton Instruments
MicroMAX; Roper Scientiﬁc) was used for the recording of epiﬂuorescence images
of oocytes incubated in M2 medium at 37 C. GFP-tagged Geminin was imaged
using a ﬁlter set comprised of an excitation ﬁlter with a band pass of 450–490 nm,
a dichroic mirror 510 nm and a band pass 505–520 nm emission ﬁlter.
A DAPI (4,6-diamidino-2-phenylindole) ﬁlter set was used for imaging Hoechst
33342 (excitation ﬁlter: 340–380 nm, dichroic mirror: 400–420 nm, emission ﬁlter:
435–485 nm). Oocytes were imaged every 15min to minimize photobleaching and
photodamage. Data were collected and analysed using MetaMorph and Meta-Fluor
software 6.1 (Molecular Devices).
Data analysis and statistics. The rate of Geminin-GFP destruction per hour was
calculated according to the formula (Fl1–Fl2)/Fl1(t2 t1). For the controls, Fl1 is the
ﬂuorescence just before the start of the metaphase to anaphase destruction phase,
while Fl2 is the ﬂuorescence at the end of the destruction phase. t1 and t2 are the
time points that correspond to Fl1 and Fl2, respectively. Background ﬂuorescence
was subtracted from cell ﬂuorescence. For Etoposide-treated oocytes, t1 and t2
represent hourly time points from 7 to 12 h post GVBD. For kinetochore ﬂuor-
escence experiments, the oocytes (control versus treated and young versus aged) of
all the replicates from the same experiment, for one SAC component, were
manipulated under the same conditions and imaged under identical settings. The
ﬂuorescence of each kinetochore was measured from a single z section. The mean
ﬂuorescence of an area surrounding the kinetochore was used as background and
was subtracted from kinetochore ﬂuorescence. Kinetochores were considered
positive for a SAC component when the ﬂuorescence was detectable after
subtracting background. For normalization, we used the values of young oocyte
kinetochores. ImageJ software was used for measuring the ﬂuorescence. For
colocalization measurements, we used z-projection images of CREST and Mad2 or
Bub1. An area including all the kinetochores of a cell in the CREST images was
used for localization comparison. The extent of colocalization was identiﬁed by the
Coloc 2 function of ImageJ. We show Pearson’s correlation coefﬁcient calculations
and values on a scale  1 to þ 1, where  1 is total negative correlation, 0 is no
correlation and þ 1 is total positive correlation. M1, M2 and Costes coefﬁcients
show the same level of colocalization. For the measurement of spindle length, a line
was drawn using ImageJ between the ﬂuorescing edges of the spindle where the
spindle poles are located. For determining spindle width, a line, perpendicular to
the line between the spindle poles, was drawn at the area of the major width of the
spindle. Statistical analysis was performed using unpaired t-tests in Prism software
(GraphPad Software). Analysis was performed for three replicate experiments,
unless otherwise stated and represented as means and s.e.m.’s.
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